Neuphoria Therapeutics
NEUP
#9921
Rank
S$22.79 M
Marketcap
$6.74
Share price
0.38%
Change (1 day)
-57.95%
Change (1 year)

Neuphoria Therapeutics (NEUP) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$5.79 Million

According to Neuphoria Therapeutics's latest financial reports the company's total liabilities are S$5.79 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neuphoria Therapeutics - Total liabilities on balance sheet (from 2022 to 2023)

Total liabilities by year

Year Total liabilities Change
2024-06-30S$13.78 M134.26%
2023-06-30S$5.88 M-26.88%
2022-06-30S$8.04 M58.98%
2021-06-30S$5.06 M-64.69%
2020-06-30S$14.32 M-40.1%
2019-06-30S$23.92 M-32.9%
2018-06-30S$35.65 M0.41%
2017-06-30S$35.5 M3.72%
2016-06-30S$34.23 M16.21%
2015-06-30S$29.45 M31.35%
2014-06-30S$22.42 M73.87%
2013-06-30S$12.89 M86.66%
2012-06-30S$6.91 M-12.57%
2011-06-30S$7.9 M30.61%
2010-06-30S$6.05 M6.56%
2009-06-30S$5.67 M-32.81%
2008-06-30S$8.45 M-5.55%
2007-06-30S$8.94 M17.01%
2006-06-30S$7.64 M22.44%
2005-06-30S$6.24 M24.63%
2004-06-30S$5.01 M8.32%
2003-06-30S$4.62 M41.59%
2002-06-30S$3.26 M968.82%
2001-06-30S$0.3 M